Provided by Tiger Trade Technology Pte. Ltd.

LISATA THERAPEUTICS INC

4.54
-0.0600-1.30%
Volume:127.84K
Turnover:585.14K
Market Cap:40.05M
PE:-2.14
High:4.66
Open:4.62
Low:4.54
Close:4.60
52wk High:4.89
52wk Low:1.81
Shares:8.82M
Float Shares:7.26M
Volume Ratio:1.04
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1247
EPS(LYR):-2.3994
ROE:-72.17%
ROA:-41.86%
PB:2.31
PE(LYR):-1.89

Loading ...

Lisata Therapeutics Announces Mutual Termination of License Agreement With Qilu Pharmaceutical for Certepetide

THOMSON REUTERS
·
Jan 27

Lisata Therapeutics Inc: Action Results in All Licenses and Other Rights Granted to Qilu Reverting to Lisata

THOMSON REUTERS
·
Jan 27

BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies

Reuters
·
Jan 21

BUZZ-Lisata jumps as Kuva Labs strikes acquisition deal

Reuters
·
Jan 21

Lisata Therapeutics Shares up 84.26% at $3.98 in Premarket Trade; to Be Acquired by Kuva Labs for $4 per Share

THOMSON REUTERS
·
Jan 21

Lisata Therapeutics to Be Acquired by Kuva Labs for $4.00 Per Share

Reuters
·
Jan 21

Lisata Therapeutics Enters Into Term Sheet to Be Acquired by Kuva Labs for $4.00 per Share in an All-Cash Tender Offer

THOMSON REUTERS
·
Jan 21

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM

Reuters
·
Jan 21

First Berlin Equity Research Reiterates Buy Rating on Lisata Therapeutics With USD 15 Price Target

Reuters
·
Nov 17, 2025

Lisata Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Alliances and Clinical Progress

Earnings Call
·
Nov 09, 2025

Lisata (LSTA) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 09, 2025

Lisata Therapeutics Q3 net loss narrows to $4.2 mln

Reuters
·
Nov 07, 2025

Lisata Therapeutics Q3 EPS USD -0.49

Reuters
·
Nov 07, 2025

Lisata Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Lisata Therapeutics Reports Positive Preclinical Results for Certepetide in ADC Combinations

Reuters
·
Nov 05, 2025

Lisata Therapeutics to Present Corporate Overview at LD Micro Main Event XIX Conference

Reuters
·
Oct 13, 2025

Lisata Therapeutics announces global license agreement with Catalent for certepetide use in antibody drug conjugates

Reuters
·
Oct 08, 2025

Lisata Therapeutics Inc - to Receive Over $10 Mln in Milestone Payments

THOMSON REUTERS
·
Oct 08, 2025

Lisata Therapeutics Announces Encouraging Preliminary Results from CENDIFOX Trial of Certepetide in Pancreatic Cancer

Reuters
·
Sep 29, 2025

Lisata Therapeutics Announces Encouraging Preliminary Results From the Pancreatic Cancer Cohort of the Cendifox Trial

THOMSON REUTERS
·
Sep 29, 2025